First partial success
Moderna wins patent dispute against Biontech/Pfizer
The US biotech company Moderna says it has won a case before the European Patent Office in its dispute with rivals Pfizer and Biontech over its coronavirus vaccine.
The European Patent Office has decided to uphold the validity of Moderna's patent EP949. It is assumed that the rivals will appeal this decision. Pfizer and Biontech initially made no statement.
Just one of several patent disputes
This is just one of several patent disputes brought by biotech companies. The EU Patent Office revoked a Moderna patent in November 2023.
In the USA, Moderna filed a patent lawsuit against Pfizer and Biontech in 2022 alleging that they had copied Moderna's Covid-19 vaccine technology. However, the patent lawsuit was interrupted in April. The US Patent and Trademark Office is to review the validity of two of the three Moderna patents in question.
This article has been automatically translated,
read the original article here.
Da dieser Artikel älter als 18 Monate ist, ist zum jetzigen Zeitpunkt kein Kommentieren mehr möglich.
Wir laden Sie ein, bei einer aktuelleren themenrelevanten Story mitzudiskutieren: Themenübersicht.
Bei Fragen können Sie sich gern an das Community-Team per Mail an forum@krone.at wenden.